Modulation of intestinal TLR4 expression in infants with neonatal opioid withdrawal syndrome
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Modulation of intestinal TLR4 expression in infants with neonatal opioid withdrawal syndrome ; day:27 ; month:12 ; year:2023 ; pages:1-7
Journal of perinatology ; (27.12.2023), 1-7
- Creator
-
Barnett, Rebecca C.
Lewis, Angela N.
Gong, Qingqing
Preston, Deborah L.
Frazer, Lauren C.
Werthammer, Joseph W.
Good, Misty
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41372-023-01859-2
- URN
-
urn:nbn:de:101:1-2024031113420495468240
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Barnett, Rebecca C.
- Lewis, Angela N.
- Gong, Qingqing
- Preston, Deborah L.
- Frazer, Lauren C.
- Werthammer, Joseph W.
- Good, Misty
- SpringerLink (Online service)
Other Objects (12)
Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS)
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study
Prediction of site-specific pharmacologic therapy among newborns with neonatal opioid withdrawal syndrome
Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)
Increased risk of severe neonatal opioid withdrawal syndrome in pregnancies with low placental ABCB1 DNA methylation
Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice
Elucidating the context for implementing nonpharmacologic care for neonatal opioid withdrawal syndrome: a qualitative study of perinatal nurses
Single high-dose buprenorphine for opioid craving during withdrawal
The Role of Lofexidine in Management of Opioid Withdrawal
Atypical presentation of opioid withdrawal, an effect of adulteration
Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS)
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study
Prediction of site-specific pharmacologic therapy among newborns with neonatal opioid withdrawal syndrome
Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)
Increased risk of severe neonatal opioid withdrawal syndrome in pregnancies with low placental ABCB1 DNA methylation
Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice
Elucidating the context for implementing nonpharmacologic care for neonatal opioid withdrawal syndrome: a qualitative study of perinatal nurses
Single high-dose buprenorphine for opioid craving during withdrawal
The Role of Lofexidine in Management of Opioid Withdrawal
Atypical presentation of opioid withdrawal, an effect of adulteration
Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS)
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study
Prediction of site-specific pharmacologic therapy among newborns with neonatal opioid withdrawal syndrome
Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)
Increased risk of severe neonatal opioid withdrawal syndrome in pregnancies with low placental ABCB1 DNA methylation
Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice
Elucidating the context for implementing nonpharmacologic care for neonatal opioid withdrawal syndrome: a qualitative study of perinatal nurses
Single high-dose buprenorphine for opioid craving during withdrawal
The Role of Lofexidine in Management of Opioid Withdrawal